Miami : du 10 au 14 novembre 2010
Neo-adjuvant chemo-hormonotherapy in Breast cancer :
which loco-regional therapy?

Organised by Eli AVISAR ( Miami)
L. LEVY and JP LEFRANC (Paris)

Radiology Topics
Assessment of breast cancer cell growth: Advantages and limitations of mammography, ultrasonography and MRI
- The role of MRI in monitoring breast cancer under neoadjuvant treatment
- Angio-mammography: New techniques in the assessment of breast cancer cell growth
- Tomosynthesis: Potential advantages in the assessment of growth and monitoring of breast cancer during treatment

I – INTRODUCTION: JP Lefranc, JPh. Spano (Paris)
Néo-adjuvant chemotherapy : the past and the present : JP Lefranc, JPh Spano
* Theorical bases : JPh. Spano /JP.Lefranc
* Results
* The use of neo-adjuvant medical therapy in France : JPh Spano
* New questions about loco-regional treatment : JP Lefranc
* Questions
Pause

* Usual pathologics criteria for neo-adjuvant treatment
* Role of frozen section during conservative surgery and sentinel node procedure
* Definitive pathologic exam : primary tumor and axillary node
* The future : genomic analysis ?
* Questions

III PART OF BREAST RADIOLOGY AND NEO-ADJUVANT CHEMOTHERAPY : radiologist
* Pre chemotherapy exploration
* Pre surgery exploration : radiologic exams and tumor response
* Questions
Lunch : (13h)

IV WHICH KINDS OF SURGICAL PROCEDURES ?: JPh Spano, JP Lefranc,
E. Touboul
* The methods
- Radical modified mastectomy, or conservative surgery (tumorectomy/segmentectomy/oncoplastic surgery)
- Axillary exploration : axillary dissection or sentinel node
* Which criteria for which surgical procedures ?
*Questions
Pause

V ROLE AFTER RADIOTHERAPY AFTER MEDICAL NEO-ADJUVANT THERAPY AND SURGERY : E Touboul
* After conservative surgery
*After radical modified mastectomy
* Questions

VI SPECIAL THERAPIC PROBLEMS
* Lobular invasive carcinoma
* Young age (≤ 35 years)
* Extensive ductal in situ component associated
* Questions

CONCLUSIONS :